Eledon Pharmaceuticals price target lowered to $20.50 from $28 at Ladenburg
The Fly

Eledon Pharmaceuticals price target lowered to $20.50 from $28 at Ladenburg

Ladenburg lowered the firm’s price target on Eledon Pharmaceuticals (ELDN) to $20.50 from $28 and keeps a Buy rating on the shares. The firm says the Phase 2 BESTOW RT study completed enrollment four months early.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App